FIELD: medicine.
SUBSTANCE: method involves quantifying of the following markers in blood serum: a1-, γ-globulin, phosphorus by a biochemical analysis of blood plasma before the therapy and after the first chemotherapeutic course; an increase of a1-globulins of min. 1.2 times, γ-globulins of 1.4-1.5 times, phosphorus of min. 3 times, the administered cytostatic agents are predicted to be effective. The invention can be used in oncology, in clinical laboratory practice for the purpose of assessing the chemotherapeutic effectiveness in malignant new growths of epithelial tissues, as well as of monitoring the clinical course of the above oncologic diseases.
EFFECT: cutting time for the prediction of the chemotherapeutic effectiveness when using the cytostatic agents, reducing cost of price of the diagnostic procedure, increasing the sensitivity of the method for the prediction of the chemotherapeutic effectiveness when using the cytostatic agents.
3 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING EFFICACY OF CYTOSTATIC CHEMOTHERAPY IN PATIENTS SUFFERING MALIGNANT NEW GROWTHS OF EPITHELIAL TISSUES | 2014 |
|
RU2546533C9 |
| METHOD FOR COMPLEX EVALUATION OF POLYCHEMOTHERAPY EFFICIENCY FOR PATIENTS WITH RECURRENT HODGKIN'S LYMPHOMA | 2016 |
|
RU2623143C1 |
| METHOD FOR PREDICTING TARGETED THERAPY EFFECTIVENESS IN PATIENTS WITH LIGHT CELL KIDNEY CANCER | 2020 |
|
RU2750026C1 |
| APPLICATION OF FUNGICIDE AS AGENT FOR TREATING ONCOLOGIC DISEASES | 2007 |
|
RU2381027C2 |
| METHOD OF NEOADJUVANT CHEMOTHERAPY OF INVASIVE BLADDER CANCER | 2008 |
|
RU2368381C1 |
| METHOD OF TREATMENT OF KIDNEY AND BLADDER MALIGNANT TUMORS | 1992 |
|
RU2007174C1 |
| METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
| METHOD FOR TREATING COMPLICATED FORMS OF URINARY BLADDER CANCER | 2003 |
|
RU2257856C1 |
| MEDICINAL COMPOSITION FOR TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS | 1996 |
|
RU2112547C1 |
| METHOD OF TREATING BLADDER CANCER | 2014 |
|
RU2581946C2 |
